G1 Therapeutics Inc (GTHX)
4.13
+0.36
(+9.55%)
USD |
NASDAQ |
May 01, 16:00
4.125
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Debt to Equity Ratio: 1.457 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.457 |
| September 30, 2023 | 1.191 |
| June 30, 2023 | 0.8851 |
| March 31, 2023 | 1.722 |
| December 31, 2022 | 1.120 |
| September 30, 2022 | 1.666 |
| June 30, 2022 | 1.147 |
| March 31, 2022 | 0.7555 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.5238 |
| September 30, 2021 | 0.1697 |
| June 30, 2021 | 0.1412 |
| March 31, 2021 | 0.1219 |
| December 31, 2020 | 0.1122 |
| September 30, 2020 | 0.0996 |
| June 30, 2020 | 0.0954 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0954
Minimum
Jun 2020
1.722
Maximum
Mar 2023
0.7472
Average
0.7555
Median
Mar 2022
Debt to Equity Ratio Benchmarks
| Amicus Therapeutics Inc | 2.422 |
| Geron Corp | 0.3305 |
| Palatin Technologies Inc | 0.00 |
| Oragenics Inc | -- |
| TG Therapeutics Inc | 0.6238 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 121.54M |
| Total Liabilities (Quarterly) | 86.15M |
| Shareholders Equity (Quarterly) | 35.39M |
| Current Ratio | 3.868 |
| Net Debt Paydown Yield | 3.16% |